Physician profile
Patrick A Stow
NPI 1518113737
$10,046.61
in general payments reported to CMS, 2019-2025
22 companies · $2,081 in 2025
The $2,081 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $110 · 2021: $322 · 2022: $1,225 · 2023: $1,586 · 2024: $4,268 · 2025: $2,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,535 · Travel and Lodging: $2,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,534.60 |
| Travel and Lodging | $2,399.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $2,693.22 | 2024-2025 | |
| Alcon Vision LLC | $1,524.52 | 2019-2025 | Precision7, Total30, Clareon |
| Bausch & Lomb Americas INC. | $1,451.56 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $844.83 | 2019-2025 | Cequa |
| Abbvie INC. | $604.51 | 2022-2025 | Vuity, Lumigan, Durysta |
| Tarsus Pharmaceuticals, INC. | $519.81 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $425.14 | 2019-2021 | |
| Coopervision INC. | $356.98 | 2019-2024 | Clariti Contact Lens, Myday Contact Lens |
| Glaukos Corporation | $294.20 | 2023-2025 | Idosetr, Ce-Marked Kxla System |
| Johnson & Johnson Vision Care, INC. | $268.62 | 2019-2024 | Acuvue |
| Allergan, INC. | $173.52 | 2019-2022 | |
| Horizon Therapeutics Plc | $149.25 | 2022-2023 | Tepezza |
| Dompe US, INC. | $147.60 | 2022-2024 | Oxervate |
| Oyster Point Pharma, INC. | $133.04 | 2023-2025 | Tyrvaya |
| Tearlab Corp | $118.15 | 2023 | Tearlab Osmolarity System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $101.15 | 2025 | Purified Cortrophin Gel |
| Harrow Eye, LLC | $67.84 | 2025 | Vevye |
| Amgen INC. | $50.13 | 2025 | Tepezza |
| Rxsight INC | $38.76 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Thea Pharma INC. | $32.67 | 2023 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $29.37 | 2022-2023 | Tecnis Iol |
| Alimera Sciences, INC. | $21.74 | 2024 | Iluvien, Yutiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Stow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.